Consolidated Statements of Operations - USD ($)	12 Months Ended
	Oct. 31, 2017	Oct. 31, 2016	[1]
Consolidated Statements of Operations
Revenues	$ 13,871,495	$ 14,892,495
Cost of expenses:
Cost of revenues	6,449,931	6,240,949
Research and development expenses	783,014	826,227
Selling, general, and administrative expenses	8,021,182	6,481,260
Total costs and expenses	15,254,127	13,548,436
(Loss)/Income from operations	(1,382,632)	1,344,059
Interest expense - related party	170,917	183,333
Other (Loss)/Income	(5,221)	0
(Loss)/Income before income taxes	(1,558,770)	1,160,726
Provision for income taxes	1,961,506	643,023
Net (loss)/income	$ (3,520,276)	$ 517,703
Net (loss)/income per common share - basic	$ (0.46)	$ 0.07
Net (loss)/income per common share - diluted	$ (0.46)	$ 0.07
Weighted average number of common shares outstanding - basic	7,693,831	7,679,696
Weighted average number of common shares outstanding - diluted	7,693,831	7,730,566

[1] Restated